Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bioimpedance Spectroscopy (BIS): Fluid Changes in Hemodialysis Patients

NCT: NCT07803029 · RECRUITING

NCT IDNCT07803029
StatusRECRUITING
Start Date2025-05-11
Completion2026-12-31
SponsorPer Ivarsen (OTHER)
First posted
Last updated

Brief Summary

In connection with dialysis treatment, fluid and salt balance changes. Some kidney disease patients experience fluid accumulation in the body and need to have excess fluid removed via the dialysis machine. Others have too little fluid in their bodies and experience general symptoms. The amount of fluid that needs to be removed is an individual assessment and can be difficult to determine. Today, fluid removal is determined based on signs such as water in the lungs, swollen legs, and blood pressure. By using a so-called bioimpedance spectroscopy (BIS) device, it os possible measure how much fluid is in the body. However, the calculations that BIS devices use are developed for healthy individuals and do not work optimally during dialysis. Therefore, the investigators will use the actual measurements and compare them with fluid extraction and weight changes to examine their relationship. Hemodialysis patients with ultrafiltration on 3 consecutive dialysis days in order to investigate whether there is a difference in measurements after the long dialysis break and whether the measurements are the same when you are being drawn to your dry weight are included. Other patients without fluid removed during dialysis will be investigated once. I the study the absolute blood volume is also measured, that is, how much fluid is in the bloodstream. This is also an expression of the body's total fluid volume. By combining the various measurements, the study will gain increased knowledge about your hydration status. If the measurement methods have sufficient precision, the use of BIS and measurement of total blood volume may contribute to a more accurate determination of your dry weight.

Frequently Asked Questions

What is Bioimpedance Spectroscopy (BIS): Fluid Changes in Hemodialysis Patients?

Bioimpedance Spectroscopy (BIS): Fluid Changes in Hemodialysis Patients is a clinical trial registered under NCT07803029. Current status: RECRUITING.

What is the status of NCT07803029?

The current status of NCT07803029 (Bioimpedance Spectroscopy (BIS): Fluid Changes in Hemodialysis Patients) is: RECRUITING.

When did Bioimpedance Spectroscopy (BIS): Fluid Changes in Hemodialysis Patients start?

Bioimpedance Spectroscopy (BIS): Fluid Changes in Hemodialysis Patients started on 2025-05-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.